Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Long Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Stock Options Stock Options [Member] Restricted Shares, Restricted Units, Performance Shares and Other Stock-Based Awards Restricted Stock [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Maximum Maximum [Member] Minimum Minimum [Member] Vesting Period [Axis] Vesting Period [Axis] Vesting Period [Axis] Vesting Period [Domain] Vesting Period [Domain] [Domain] for Vesting Period [Axis] Vest Ratably Over Three Years Vest Ratably Over Three Years [Member] Vest Ratably Over Three Years Vest In Three Years Vest In Three Years [Member] Vest In Three Years Vest After One Year Vest After One Year [Member] Vest After One Year [Member] Vest After Two Years Vest After Two Years [Member] Vest After Two Years [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Common stock shares reserved for issuance to employees Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Stock option award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Stock option award expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Period after which equity based award expires. Average remaining contractual term for options outstanding (years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Average remaining contractual term for options vested and expected to vest (years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Average remaining contractual term for options exercisable (years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate intrinsic value for options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value for options vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value for options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Granted, number of restricted stock awards Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Total unrecognized compensation expense, net of estimated forfeitures Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized Weighted-average period over which total unrecognized compensation expense expected to be recognized (years) Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Business Segments [Axis] Business Segments [Axis] Segment [Domain] Segment [Domain] Generics Segment Generics Segment [Member] Generics Segment. Specialty Segment Specialty Segment [Member] Specialty Segment. Goodwill [Line Items] Goodwill [Line Items] Goodwill, gross Goodwill, Gross Accumulated impairment losses Goodwill, Impaired, Accumulated Impairment Loss Goodwill, net, beginning balance Goodwill Goodwill acquired Goodwill, Acquired During Period Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Goodwill, net, ending balance Income Tax Disclosure [Abstract] Unrecognized tax benefit — beginning of year Unrecognized Tax Benefits Additions for current year tax positions Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions Additions for prior year tax positions Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions Reductions for prior year tax positions Unrecognized Tax Benefits, Decreases Resulting from Prior Period Tax Positions Settlements Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities Reductions due to expirations of statute of limitations Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations Foreign currency translation Unrecognized Tax Benefits, Increases Resulting from Foreign Currency Translation Addition due to acquisition Unrecognized Tax Benefits, Increases Resulting from Acquisition Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Loans Payable Loans Payable [Member] Convertible Debt Convertible Debt [Member] Senior Notes Senior Notes [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] U.S. Term Loans U.S. Term Loans [Member] U.S. Term Loans Convertible Notes Payable Convertible Notes Payable [Member] 2017 Senior Notes Senior Notes Two Thousand Seventeen [Member] Senior Notes Two Thousand Seventeen [Member] 2018 Senior Notes Senior Notes Two Thousand Eighteen [Member] Senior Notes Two Thousand Eighteen. 2020 Senior Notes Senior Notes Two Thousand Twenty [Member] Senior Notes Two Thousand Twenty [Member] 2023 Senior Notes Senior Notes Two Thousand Twenty Three [Member] Senior Notes Two Thousand Twenty Three [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] 2013 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2014 Long-term Debt, Maturities, Repayments of Principal in Year Two 2015 Long-term Debt, Maturities, Repayments of Principal in Year Three 2016 Long-term Debt, Maturities, Repayments of Principal in Year Four 2017 Long-term Debt, Maturities, Repayments of Principal in Year Five Thereafter Long-term Debt, Maturities, Repayments of Principal after Year Five Total Long-term Debt, Gross Business Combinations [Abstract] Business Combinations Policy Business Combinations Policy [Policy Text Block] Segment Reporting [Abstract] Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Information by Financial Statement Line Item [Axis] Information by Financial Statement Line Item [Axis] Financial Statement Classification [Domain] Financial Statement Classification [Domain] Financial Statement Classification [Domain] Net Revenues Sales Revenue, Goods, Net [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Allergy Allergy [Member] Allergy [Member] Anti-infectives Anti Infective Agents [Member] Anti Infective Agents [Member] Cardiovascular Cardiovascular [Member] Cardiovascular [Member] Central Nervous System Central Nervous System [Member] Central Nervous System [Member] Dermatological Dermatological [Member] Dermatological Endocrine and Metabolic Endocrine And Metabolic [Member] Endocrine And Metabolic [Member] Gastrointestinal Gastrointestinal [Member] Gastrointestinal [Member] Respiratory System Respiratory Agents [Member] Respiratory Agents [Member] Other Other Products [Member] Other Products [Member] Product Information [Line Items] Product Information [Line Items] Net revenues Sales Revenue, Goods, Net Therapeutic class disclosure threshold Therapeutic Class Reporting Threshold Threshold for disclosure of individual therapeutic class, percentage of total category Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected term of options (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Forfeiture rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate Share-based compensation arrangement bysShare-based payment award, fair value assumptions, Forfeiture rate Weighted average grant date fair value per option Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Long-Term Debt Long-term Debt [Text Block] Statement of Cash Flows [Abstract] Statement [Table] Statement [Table] Statement, Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement [Line Items] Statement [Line Items] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Stock-based compensation expense Share-based Compensation Change in estimated sales allowances Change in estimated sales allowances The net change during the reporting period in the amount of sales allowances relating to provisions for estimates, including discounts, volume-based sales allowances, price adjustments, returns, chargebacks and other promotional programs. Deferred income tax (benefit) expense Deferred Income Tax Expense (Benefit) Other non-cash items Other Noncash Income (Expense) Litigation settlements, net Gain (Loss) Related to Litigation Settlement Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Trade accounts payable Increase (Decrease) in Accounts Payable, Trade Income taxes Increase (Decrease) in Income Taxes Payable Deferred revenue Increase (Decrease) in Deferred Revenue Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Change in restricted cash Proceeds from (Repayments of) Restricted Cash, Financing Activities Cash paid for acquisitions, net Payments to Acquire Businesses, Net of Cash Acquired Proceeds from sale of property, plant and equipment Proceeds from Sales of Assets, Investing Activities Purchase of marketable securities Payments to Acquire Marketable Securities Proceeds from sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Other items, net Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Cash dividends paid Payments of Ordinary Dividends, Preferred Stock and Preference Stock Payment of financing fees Payments of Financing Costs Cash paid for warrant amendment and exchange Payment for Warrant Amendment and Exchange Payment for warrant amendment and exchange Purchase of common stock Payments for Repurchase of Common Stock Change in short-term borrowings, net Proceeds from (Repayments of) Short-term Debt Proceeds from issuance of long-term debt Proceeds from Issuance of Long-term Debt Payment of long-term debt Repayments of Long-term Debt Proceeds from exercise of stock options Proceeds from Stock Options Exercised Other items, net Proceeds from (Payments for) Other Financing Activities Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash and Cash Equivalents Net (decrease) increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents — beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents — end of period Supplemental disclosures of cash flow information — Supplemental Cash Flow Elements [Abstract] Non-cash transactions: Noncash Investing and Financing Items [Abstract] Other long-term obligations Other Significant Noncash Transaction, Value of Consideration Given Cash paid during the period for: Supplemental Cash Flow Information [Abstract] Income taxes Income Taxes Paid Interest Interest Paid Contingencies [Abstract] Contingencies. Loss Contingencies [Table] Loss Contingencies [Table] Litigation, Defendants [Axis] Litigation, Defendants [Axis] Litigation, Defendants Litigation, Defendants [Domain] Litigation, Defendants [Domain] [Domain] for Litigation, Defendants Other Drug Manufacturers Other Drug Manufacturers [Member] Other drug manufacturers Other Companies Other Companies [Member] Other companies Litigation Case [Axis] Litigation Case [Axis] Litigation Case Type [Domain] Litigation Case Type [Domain] Lorazepam And Clorazepate Lorazepam And Clorazepate [Member] Lorazepam And Clorazepate. Pricing And Medicaid Litigation Pricing And Medicaid Litigation [Member] Pricing and Medicaid Litigation. Modafinil Antitrust Litigation and FTC Inquiry Modafinil Antitrust Litigation and FTC Inquiry [Member] Modafinil Antitrust Litigation and FTC Inquiry. EU Commission Proceedings EU Commission Proceedings [Member] EU Commission Proceedings Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Mylan Specialty Mylan Specialty [Member] Mylan Specialty [Member] Geographical [Axis] Geographical [Axis] Segment, Geographical [Domain] Segment, Geographical [Domain] New York State NEW YORK Litigation, Plaintiffs [Axis] Litigation, Plaintiffs [Axis] Litigation, Plaintiffs Litigation, Plaintiffs [Domain] Litigation, Plaintiffs [Domain] [Domain] for Litigation, Plaintiffs Health Insurers Health Insurers [Member] Health insurers Counties Counties [Member] Counties Litigation Information [Axis] Litigation Information [Axis] Litigation information Litigation Information [Domain] Litigation Information [Domain] [Domain] for Litigation information Found In Violation of Antitrust Laws Found In Violation of Antitrust Laws [Member] Found by jury to be in violation of antitrust laws Motion to Dismiss Filed Motion to Dismiss Filed [Member] A related motion to dismiss was filed Judgment Issued Judgment Issued [Member] Judgment issued Judgment Reflects Trebling Of Compensatory Damages Judgment Reflects Trebling Of Compensatory Damages [Member] Judgment reflects trebling of compensatory damages in original verdict Original Verdict Original Verdict [Member] Original verdict Original Verdict Plus Punitive Damages Original Verdict Plus Punitive Damages [Member] Original verdict plus punitive damages Other Award Sought Other Award Sought [Member] Other award sought Plaintiff Bond Plaintiff Bond [Member] Bond required to be posted by plaintiff Loss Contingencies by Nature of Contingency [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Surety Bond Surety Bond [Member] Indemnification Agreement Indemnification Agreement [Member] Antitrust Proceedings Antitrust Proceedings [Member] Antitrust proceedings Product Liability Product Liability [Member] Product Liability Intellectual Property Developed Technology Rights [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Loss contingency accrual Loss Contingency Accrual, at Carrying Value Number of drugs Number of drugs Number of drugs Number of plaintiffs Loss Contingency, Number of Plaintiffs Damages awarded Loss Contingency, Damages Awarded, Value Damages sought Loss Contingency, Damages Sought, Value Voluntary remittitur from plaintiffs Voluntary remittitur from plaintiffs The voluntary remittitur from plaintiffs Bond Bond, Value Bond, value Loss contingency accrual, payments Loss Contingency Accrual, Carrying Value, Payments Loss contingency accrual, provision Loss Contingency Accrual, Carrying Value, Provision Other current liabilities Other Liabilities, Current Number of other drug manufactures named as defendants in the civil lawsuit Loss Contingency, Number of Defendants Loss contingency accrual, carrying value, period increase (decrease) Loss Contingency Accrual, Carrying Value, Period Increase (Decrease) Injunction period post mandate Injunction period post mandate Injunction period post mandate Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Product rights and licenses Licensing Agreements [Member] Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In-Process Research and Development [Member] In-Process Research and Development Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Respiratory Delivery Platform The Respiratory Delivery Platform [Member] The Respiratory Delivery Platform Bioniche Pharma Holdings Limited Bioniche Pharma Holdings Limited [Member] Bioniche Pharma Holdings Limited Other Business Acquisitions Series of Individually Immaterial Business Acquisitions [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Acquisition purchase price Business Acquisition, Cost of Acquired Entity, Purchase Price Purchase consideration, cash paid Business Acquisition, Cost of Acquired Entity, Cash Paid Purchase consideration, assumed liabilities Business Acquisition, Purchase Price Allocation, Liabilities Assumed Purchase consideration, contingent consideration Business Acquisition, Contingent Consideration, at Fair Value Purchase price allocation, IPR&D Business Acquisition, Purchase Price Allocation, Intangible Assets Not Amortizable Purchase price allocation, fixed assets Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment Purchase price allocation, goodwill Business Acquisition, Purchase Price Allocation, Goodwill Amount Rate used to discount net cash inflows to present values Fair Value Inputs, Discount Rate Percentage of outstanding equity acquired Business Acquisition, Percentage of Voting Interests Acquired Purchase price allocation, identified intangible assets Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets Finite-lived intangible assets, weighted average useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquisition costs Business Combination, Acquisition Related Costs Amortization of step-up of fair value of inventory Amortization of Fair Value Inventory Step Up Amortization of acquired inventory fair value step-up Business acquisition pro forma amortization of fair value of inventory costs. Amortization of acquired intangible assets Amortization of Acquired Intangible Assets Number of businesses acquired Number of Businesses Acquired Deferred tax assets: Deferred Tax Assets, Net [Abstract] Deferred tax assets, Employee benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Deferred tax assets, Legal matters Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements Deferred tax assets, Accounts receivable allowances Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts Deferred tax assets, Inventories Deferred Tax Assets, Inventory Deferred tax assets, Other reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves Deferred tax assets, Tax credits Deferred Tax Assets, Tax Credit Carryforwards Deferred tax assets, Net operating losses carryforward Deferred Tax Assets, Operating Loss Carryforwards Deferred tax assets, Intangible assets Deferred Tax Assets Intangible Assets Deferred Tax Assets Intangible Assets Deferred tax assets, Capital loss carryforward Deferred Tax Assets, Capital Loss Carryforwards Deferred tax assets, Convertible debt Deferred Tax Assets Convertible Debt Deferred tax assets convertible debt. Deferred tax assets, Other Deferred Tax Assets, Other Total deferred tax assets, gross Deferred Tax Assets, Gross Less: Valuation allowance Deferred Tax Assets, Valuation Allowance Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Deferred tax liabilities, Plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Deferred tax liabilities, Intangibles Deferred Tax Liabilities, Intangible Assets Deferred tax liabilities, Other Deferred Tax Liabilities, Other Total deferred tax liabilities Deferred Tax Liabilities, Net Deferred tax assets (liabilities), net Deferred Tax Assets, Net Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Nonvested, Number of Restricted Stock Awards, Beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Nonvested, Weighted Average Grant-Date Fair Value per Share, Beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted, Weighted Average Grant-Date Fair Value per Share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Released, Number of Restricted Stock Awards Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Released, Weighted Average Grant-Date Fair Value per Share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited, Number of Restricted Stock Awards Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited, Weighted Average Grant-Date Fair Value per Share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Nonvested, Number of Restricted Stock Awards, Ending balance Nonvested, Weighted Average Grant-Date Fair Value per Share, Ending balance Amortization expense Amortization of Intangible Assets Expected amortization expense, 2013 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Expected amortization expense, 2014 Finite-Lived Intangible Assets, Amortization Expense, Year Two Expected amortization expense, 2015 Finite-Lived Intangible Assets, Amortization Expense, Year Three Expected amortization expense, 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Four Expected amortization expense, 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Five Impairment charge, IPR&D Indefinite-lived Intangible Assets, Impairment Losses Discount rate used in valuation of IPR&D Acquired IPR&D assets reclassified to product rights and licenses Intangible Assets Reclassified from Non Amortizable to Amortizable Intangible assets reclassified from non amortizable to amortizable Payment to acquire intangible assets Payments to Acquire Intangible Assets Number of products acquired Acquired Finite-lived Intangible Assets, Number of Products Acquired Finite-lived Intangible Assets, Number of Products Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Value Hedging Relationships Fair Value Hedging [Member] Derivative Instrument Risk [Axis] Derivative Instrument Risk [Axis] Derivative Contract Type [Domain] Derivative Contract Type [Domain] Interest rate swaps Interest Rate Swap [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Interest expense Interest Expense [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Amount of Gain Recognized in Earnings on Derivatives Derivative Instruments, Gain (Loss) Recognized in Income, Net Amount of Loss Recognized in Earnings on Hedging Items Gain (Loss) on Fair Value Hedges Recognized in Earnings Accounting Policies [Abstract] Principles Of Consolidation Policy Consolidation, Policy [Policy Text Block] Use Of Estimates In The Preparation Of Financial Statements Policy Use of Estimates, Policy [Policy Text Block] Foreign Currencies Policy Foreign Currency Transactions and Translations Policy [Policy Text Block] Cash And Cash Equivalents Policy Cash and Cash Equivalents, Policy [Policy Text Block] Marketable Securities Policy Marketable Securities, Policy [Policy Text Block] Concentrations Of Credit Risk Policy Concentration Risk, Credit Risk, Policy [Policy Text Block] Inventories Policy Inventory, Policy [Policy Text Block] Property, Plant And Equipment Policy Property, Plant and Equipment, Policy [Policy Text Block] Intangible Assets And Goodwill Policy Goodwill and Intangible Assets, Policy [Policy Text Block] Contingent Consideration Policy Contingent Consideration, Policy [Policy Text Block] Contingent consideration [Policy Text Block] Impairment Of Long-Lived Assets Policy Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Revenue Recognition Policy Revenue Recognition, Policy [Policy Text Block] Research And Development Policy Research and Development Expense, Policy [Policy Text Block] Income Taxes Policy Income Tax, Policy [Policy Text Block] Earnings Per Common Share Policy Earnings Per Share, Policy [Policy Text Block] Stock-Based Compensation Policy Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Derivatives Policy Derivatives, Policy [Policy Text Block] Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Short-term Debt Short-term Debt [Member] Short-Term Borrowings Policy Debt, Policy [Policy Text Block] Quarterly Financial Data [Abstract] Quarterly Financial Data [Table] Schedule of Quarterly Financial Information [Table] Schedule of Quarterly Financial Information [Table] Quarterly Financial Data [Line Items] Quarterly Financial Information [Line Items] Quarterly Financial Information [Line Items] Total revenues Revenue, Net Gross profit Gross Profit Net earnings attributable to Mylan Inc. common shareholders Net Income (Loss) Available to Common Stockholders, Basic Basic Earnings Per Share, Basic Diluted Earnings Per Share, Diluted Share prices, high Market Price Per Share High High closing market price per share. Share prices, low Market Price Per Share Low Low closing market price per share. Net Investment Hedging Relationships Net Investment Hedging [Member] Foreign currency borrowings Foreign Currency Borrowings [Member] Foreign currency borrowings. Amount of Gain or (Loss) Recognized in AOCE (Net of Tax) on Derivative (Effective Portion) Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Schedule of Purchase Price Allocation Schedule of Purchase Price Allocation [Table Text Block] Pro Forma Financial Information Business Acquisition, Pro Forma Information [Table Text Block] Senior Convertible Notes Senior Convertible Notes [Member] Senior Convertible Notes. Face value Debt Instrument, Face Amount Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Long-term debt Long-term Debt Discount on debt Debt Instrument, Unamortized Discount Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Contingencies Legal Matters and Contingencies [Text Block] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Schedule of Available-for-sale Securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Mature within one year Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Mature in one to five years Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value Mature in five years and later Available for Sale Securities Debt Maturities after Five Years and Later Fair Value Available for sale securities debt maturities after five years and later fair value. Available-for-sale securities, debt securities Available-for-sale Securities, Debt Securities Supplementary Financial Information Quarterly Financial Information [Text Block] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Fair Value Hedging Cash Flow Hedging Cash Flow Hedging [Member] Net Investment Hedging Derivative [Line Items] Derivative [Line Items] Schedule of Derivative Instruments in Statement of Financial Position at Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Effect of Derivative Instruments on the Consolidated Statements of Operations Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block] Financial Assets And Liabilities Carried At Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Available-for-sale Securities Reconciliation Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Maturities Of Available-For-Sale Debt Securities At Fair Value Investments Classified by Contractual Maturity Date [Table Text Block] Commitments [Abstract] Commitments. Commitments Commitments Disclosure [Text Block] Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Patents and technologies Patents [Member] Other Other Intangible Assets [Member] Intangible Assets Excluding Goodwill [Line Items] Finite-Lived Intangible Assets [Line Items] Weighted Average Life (Years) Finite-Lived Intangible Asset, Useful Life Original Cost Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Net Book Value Finite-Lived Intangible Assets, Net IPR&D Indefinite-Lived Intangible Assets (Excluding Goodwill) Original Cost, Total intangible assets Intangible Assets Gross Excluding Goodwill Intangible assets gross excluding goodwill Net Book Value, Total intangible assets Intangible Assets, Net (Excluding Goodwill) Stock-Based Incentive Plan Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Preferred And Common Stock [Abstract] Preferred and common stock. Preferred And Common Stock Preferred Stock [Text Block] Statement of Stockholders' Equity [Abstract] Statement, Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Preferred Stock Preferred Stock [Member] Common Stock Common Stock [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Retained Earnings Retained Earnings [Member] Treasury Stock Treasury Stock [Member] Accumulated Other Comprehensive Earnings (Loss) Accumulated Other Comprehensive Income (Loss) [Member] Noncontrolling Interest Noncontrolling Interest [Member] Beginning balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Beginning balance (in shares) Shares, Issued Other comprehensive earnings (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Common stock share repurchase Treasury Stock, Value, Acquired, Cost Method Common stock share repurchase (in shares) Treasury Stock, Shares, Acquired Warrant amendment and exchange Equity Effect Of Warrant Amendment And Exchange Equity effect of warrant amendment and exchange. Stock options exercised, net of shares tendered for payment Stock Issued During Period, Value, Stock Options Exercised Stock options exercised, net of shares tendered for payment (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Preferred stock conversion Conversion of Stock, Amount Converted Preferred stock conversion (in shares) Conversion of Stock, Shares Converted Preferred stock conversion Conversion of Stock, Amount Issued Preferred stock conversion (in shares) Conversion of Stock, Shares Issued Stock compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Issuance of restricted stock, net of shares withheld Restricted Stock, Value, Shares Issued Net of Tax Withholdings Issuance of restricted stock, net of shares withheld (in shares) Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Tax benefit of stock option plans Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Dividends on preferred shares Dividends, Preferred Stock, Cash Purchase of subsidiary shares from noncontrolling interest Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Other Stockholders' Equity, Other Ending balance Ending balance (in shares) Number of Reportable Segments Number of Reportable Segments Organization, Consolidation and Presentation of Financial Statements [Abstract] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Business Acquisition, Purchase Price Allocation [Abstract] Business Acquisition, Purchase Price Allocation [Abstract] Current assets (excluding inventories) Business Acquisition Purchase Price Allocation Current Assets Excluding Inventories Business acquisition purchase price allocation current assets excluding inventories. Inventories Business Acquisition, Purchase Price Allocation, Current Assets, Inventory Property, plant and equipment, net Identified intangible assets In-process research and development Goodwill Total assets acquired Business Acquisition, Purchase Price Allocation, Assets Acquired Current liabilities Business Acquisition, Purchase Price Allocation, Current Liabilities Deferred tax liabilities Business Acquisition, Purchase Price Allocation, Deferred Taxes Asset (Liability), Net, Noncurrent Other non-current liabilities Business Acquisition, Purchase Price Allocation, Other Noncurrent Liabilities Net assets acquired Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net Equity [Abstract] Unrecognized loss and prior service cost arising during the period Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments and Tax Less: Actuarial loss included in net earnings Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, before Tax Less: Amortization of prior service cost included in net earnings Other Comprehensive Income (Loss), Amortization, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost Recognized in Net Periodic Benefit Cost, before Tax Net change in unrecognized loss and prior service cost related to defined benefit plans Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Tax Amount of gain (loss) recognized in AOCE on derivatives (effective portion) Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Less: Reclassification of loss from AOCE into earnings (effective portion) Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax Net unrecognized gain (loss) on derivatives Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Unrealized (loss) gain on marketable securities Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, before Tax Less: Reclassification for gain (loss) included in net earnings Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax Net unrealized (loss) gain on marketable securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax Debt Securities Debt Securities [Member] Equity securities Equity Securities [Member] Amortized Cost Available-for-sale Securities, Amortized Cost Basis Gross Unrealized Gains Available-for-sale Securities, Gross Unrealized Gains Gross Unrealized Losses Available-for-sale Securities, Gross Unrealized Losses Fair Value Available-for-sale Securities, Fair Value Disclosure Quarterly Financial Data Schedule of Quarterly Financial Information [Table Text Block] Changes In Carrying Amount Of Goodwill Schedule of Goodwill [Table Text Block] Components Of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Product Rights And Licenses By Therapeutic Category Product Rights And Licenses By Therapeutic Category [Table Text Block] Product rights and licenses by therapeutic category Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Purchased cash convertible note hedge Purchased Cash Convertible Note Hedge [Member] Purchased cash convertible note hedge. Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Measurements, Fair Value Hierarchy [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Asset Class [Axis] Asset Class [Axis] Fair Value by Asset Class [Domain] Fair Value by Asset Class [Domain] Money market funds Money Market Funds [Member] Equity securities — exchange traded funds Exchange Traded Funds [Member] Available-for-sale fixed income investments U.S. Treasuries US Treasury Securities [Member] Corporate bonds Corporate Bond Securities [Member] Agency mortgage-backed securities Collateralized Mortgage Backed Securities [Member] Other Other Debt Obligations [Member] Total available-for-sale equity securities Biosciences industry Interest rate swap derivatives Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Cash conversion feature of Cash Convertible Notes Cash Conversion Feature Of Cash Convertible Notes [Member] Cash conversion feature of cash convertible notes. Contingent consideration Contingent Consideration [Member] Contingent Consideration [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash equivalents, fair value Cash and Cash Equivalents, Fair Value Disclosure Trading securities, fair value Trading Securities, Fair Value Disclosure Available-for-sale securities, fair value Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Interest rate swap derivative assets Derivative Assets Convertible debt, fair value Convertible Debt, Fair Value Disclosures Total assets at fair value Assets, Fair Value Disclosure Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Interest rate swap derivative liabilities Derivative Financial Instruments, Liabilities, Fair Value Disclosure Contingent consideration Other Liabilities, Fair Value Disclosure Total liabilities at fair value Liabilities, Fair Value Disclosure Document And Entity Information [Abstract] Document and Entity Information. Document Information [Table] Document Information [Table] Document Information, Document [Axis] Document Information, Document [Axis] Document [Domain] Document [Domain] Document Information [Line Items] Document Information [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Current Fiscal Year End Date Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Filer Category Entity Filer Category Entity Public Float Entity Public Float Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Business Acquisition, Pro Forma Information [Abstract] Business Acquisition, Pro Forma Information [Abstract] Total revenues Business Acquisition, Pro Forma Revenue Net earnings attributable to Mylan Inc. before preferred dividends Business Acquisition Pro Forma Net Income Loss Before Preferred Dividends Business acquisition pro forma net income loss before preferred dividends. Preferred dividends Business Acquisition Pro Forma Preferred dividends Business acquisition pro forma preferred dividends. Net earnings attributable to Mylan Inc. common shareholders Business Acquisition, Pro Forma Net Income (Loss) Earnings per common share attributable to Mylan Inc. common shareholders: Earnings Per Share [Abstract] Basic Business Acquisition, Pro Forma Earnings Per Share, Basic Diluted Business Acquisition, Pro Forma Earnings Per Share, Diluted Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Basic Business acquisition pro forma weighted average common shares outstanding basic. Diluted Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Diluted Business acquisition pro forma weighted average common shares outstanding diluted. 2013 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2014 Operating Leases, Future Minimum Payments, Due in Two Years 2015 Operating Leases, Future Minimum Payments, Due in Three Years 2016 Operating Leases, Future Minimum Payments, Due in Four Years 2017 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total operating lease minimum commitments Operating Leases, Future Minimum Payments Due Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Old Warrants Old Warrants [Member] Old Warrants [Member] New Warrants New Warrants [Member] New Warrants [Member] Call Option Call Option [Member] Cash Convertible Notes Cash Convertible Notes [Member] Cash convertible notes [Member] Conversion reference rate, per $1,000 principal amount of notes Debt Instrument, Convertible, Conversion Ratio Reference Principal Amount Reference Principal Amount Of Cash Convertible Notes Reference principal amount of Cash Convertible Notes to which the ratio is applied to the debt for purposes of determining the number of shares of the equity security into which the debt will be converted. Conversion reference price Debt Instrument, Convertible, Conversion Price Number of common stock issuable for warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Exercise price of warrants issued Class of Warrant or Right, Exercise Price of Warrants or Rights Long-term debt, current maturities Long-term Debt, Current Maturities Number of warrants exchanged Number of warrants exchanged Number of warrants exchanged Cash paid per warrant for amendment Amount Paid Per Warrant To Holders Amount Paid Per Warrant To Holders Cash paid for amendment of warrant agreement Amount Paid To Warrant Holders Total Amount Paid To Warrant Holders Total Debt, Long-term and Short-term, Combined Amount Debt, Long-term and Short-term, Combined Amount Convertible debt instrument, carrying amount of the equity component Debt Instrument, Convertible, Carrying Amount of Equity Component Convertible debt instrument, fair value of associated derivative transaction Investment Owned, at Fair Value Ratio of observed share price to conversion reference price Ratio Of Observed Share Price To Conversion Reference Price Ratio Of Observed Share Price To Conversion Reference Price Percent of closing price of common stock and conversion reference rate Percent Of Closing Price Of Common Stock And Conversion Reference Rate Percent of the product of the closing price of common stock on a certain day and the applicable conversion reference rate Reference consecutive trading days Reference Consecutive Trading Days Reference Consecutive Trading Days Consecutive trading days Consecutive Trading Days Consecutive Trading Days Trading days Trading Days Trading Days Statement of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Accounts receivable, net Accounts Receivable, Net, Current Inventories Inventory, Net Deferred income tax benefit Deferred Tax Assets, Net of Valuation Allowance, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Intangible assets, net Goodwill Deferred income tax benefit Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Other assets Other Assets, Noncurrent Total assets Assets Liabilities and Equity Liabilities and Equity [Abstract] Liabilities Liabilities [Abstract] Current liabilities: Liabilities, Current [Abstract] Trade accounts payable Accounts Payable, Trade, Current Short-term borrowings Short-term Debt Income taxes payable Accrued Income Taxes, Current Current portion of long-term debt and other long-term obligations Current portion of long term debt and other long term obligations Total of the portions of the carrying amounts as of the balance sheet date of long-term debt, which may include notes payable, bonds payable, debentures, mortgage loans, and commercial paper, which are scheduled to be repaid within one year or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any, as well as the current maturities of other noncurrent liabilities not otherwise specified in the taxonomy, which are due within one year (or one business cycle if longer). Deferred income tax liability Deferred Tax Liabilities, Net, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Other long-term obligations Other Liabilities, Noncurrent Deferred income tax liability Deferred Tax Liabilities, Net, Noncurrent Total liabilities Liabilities Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Mylan Inc. shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Common stock — par value $0.50 per share; shares authorized: 1,500,000,000; shares issued: 539,664,386 and 530,315,453 as of December 31, 2012 and December 31, 2011 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total Mylan Inc. shareholders' equity, before treasury stock StockholdersEquityParentBeforeTreasuryStock Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings that are attributable to the parent company, excluding equity attributable to noncontrolling interests, and before deducting the carrying value of treasury stock. Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Less: treasury stock — at cost; shares: 144,459,210 and 103,637,016 as of December 31, 2012 and December 31, 2011 Treasury Stock, Value Total equity Total liabilities and equity Liabilities and Equity Reconciliation Of Segment Information To Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Net Revenues Classified Based On Therapeutic Product Categories Revenue from External Customers by Products and Services [Table Text Block] Net Revenues Classified Based On Geographic Location Of Customers Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Contingent consideration, value Business Acquisition, Contingent Consideration, Potential Cash Payment Derivative, by Nature [Axis] Derivative, by Nature [Axis] Derivative, Name [Domain] Derivative, Name [Domain] Swapped to Fixed Rate 2016 Swapped to Fixed Rate Two Thousand Sixteen [Member] Swapped to Fixed Rate March to November Two Thousand Sixteen Swapped To Fixed Rate Through January 2014 Swapped To Fixed Rate January Two Thousand Fourteen [Member] Swapped To Fixed Rate January Two Thousand Fourteen Swapped To Fixed Rate Through March 2014 Swapped To Fixed Rate March Two Thousand Fourteen [Member] Swapped To Fixed Rate March Two Thousand Fourteen Floating Rate Floating Rate Debt [Member] Floating Rate Debt [Member] Description of variable rate basis Debt Instrument, Description of Variable Rate Basis Debt instrument, interest rate at period end Debt Instrument, Interest Rate at Period End Derivative, fixed interest rate Derivative, Fixed Interest Rate Notional amount of interest rate cash flow hedge derivatives Notional Amount of Interest Rate Cash Flow Hedge Derivatives Debt instrument, basis spread on fixed rate Debt Instrument Basis Spread On Fixed Rate Debt Instrument Basis Spread On Fixed Rate Goodwill And Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Financial Instruments And Risk Management Financial Instruments Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Funding [Axis] Funding [Axis] Funding [Axis] Funding [Domain] Funding [Domain] [Domain] for Funding [Axis] Committed Financing Committed Financing [Member] Committed financing Agila Specialties Private Limited Agila Specialties Private Limited [Member] Agila Specialties Private Limited [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Business acquisition, contingent payments Schedule of Components of Income Tax Provision (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Statutory Tax Rate To Effective Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block] Income Taxes Income Tax Disclosure [Text Block] Schedule Of Operating Leases Operating Leases of Lessee Disclosure [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Compensation and Retirement Disclosure [Abstract] Employee Benefits Pension and Other Postretirement Benefits Disclosure [Text Block] Inventories [Table] Schedule of Inventory, Net [Table] Schedule of Inventory, Net Inventories [Line Items] Schedule of Inventory, Net [Line Items] [Line Items] for Schedule of Inventory, Net Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventories Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Table] Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Table] Schedule of Earnings Per Share, Basic and Diluted, by Common Class Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Schedule Of Earnings Per Share Basic And Diluted By Common Class [Line Items] Schedule Of Earnings Per Share Basic And Diluted By Common Class [Line Items] Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] Net earnings attributable to Mylan Inc. before preferred dividends Net Income (Loss) Attributable to Parent Preferred dividends Preferred Stock Dividends, Income Statement Impact Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Basic earnings per common share attributable to Mylan Inc. common shareholders Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Weighted Average Number Diluted Shares Outstanding Adjustment Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Diluted earnings per common share attributable to Mylan Inc. Foreign currency forward contracts Foreign Exchange Contract [Member] Other income (expense), net Other Income [Member] Amount of Gain or (Loss) Recognized in Earnings on Derivatives Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Statement of Other Comprehensive Income [Abstract] Other comprehensive earnings (loss), before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Change in unrecognized loss and prior service cost related to defined benefit plans Other comprehensive earnings (loss), before tax Other Comprehensive Income (Loss), before Tax Income tax related to items of other comprehensive earnings (loss) Other Comprehensive Income (Loss), Tax Other comprehensive earnings (loss), net of tax Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive earnings attributable to the noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive earnings attributable to Mylan Inc. common shareholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Debt Instrument Maturity Date [Axis] Debt Instrument Maturity Date [Axis] Debt Instrument Maturity Date [Axis] Debt Instrument Maturity Date [Domain] Debt Instrument Maturity Date [Domain] Debt Instrument Maturity Date [Domain] Redeemable Prior to Maturity Redeemable Prior To Maturity [Member] Redeemable Prior To Maturity Interest Rate Contract Interest Rate Contract [Member] U.S. Tranche B Term Loans U.S. Tranche B Term Loans [Member] U.S. Tranche B Term Loans U.S. Tranche A Term Loans U.S. Tranche A Term Loans & U.S. Tranche B Term Loans [Member] U.S. Tranche A Term Loans & U.S. Tranche B Term Loans Issue price of notes percentage Issue Price Of Notes Percentage Issue Price Of Notes Percentage Effective yield to maturity Premium on debt Debt Instrument, Unamortized Premium Equivalent percentage of redeemed amount Equivalent Price Percentage Of Principal Amount Redeemable Percentage price equivalent at which long-term debt principal amount is redeemable prior to a specified date. Percentage redeemable of the aggregate principal amount Percentage Redeemable Of Aggregate Principal Amount At Specified Redemption Price Percentage of aggregate principal amount of long-term debt that is redeemable at a specified redemption price Percentage offered to repurchase in case of change of control events Percentage Offered To Repurchase Incase Of Change Of Control Events Percentage offered to repurchase incase of change of control events. Fair value adjustment Liabilities, Fair Value Adjustment Repayment of long-term debt Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Schedule of Short-term Debt Instruments [Table] Schedule of Short-term Debt [Table] Receivables Facility Receivables Facility [Member] Receivables facility. Short-term Debt [Line Items] Short-term Debt [Line Items] Receivables Facility maximum borrowing capacity Accounts Receivable Facility Maximum Borrowing Capacity Accounts receivable facility maximum borrowing capacity. Receivables Facility, maximum commitment limit Accounts Receivable Facility Maximum Commitment Limit Accounts receivable facility maximum commitment limit. Maturity period of the agreement (years) Credit Facility, Maturity Period Credit Facility, Maturity Period Securitized accounts receivable Accounts Receivable from Securitization Interest rate on borrowings Accounts Receivable Facility Interest Rate At Period End Accounts receivable facility interest rate at the end of the reporting period. Stock Option Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Status Of Company's Nonvested Restricted Stock And Restricted Stock Unit Awards And Changes Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Stock-Based Compensation Plans, Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Subsequent Event Subsequent Events [Text Block] Acquisitions And Other Transactions Business Combination Disclosure [Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Prepaid expenses and other current assets Other Current Assets [Member] Other assets Other Assets [Member] Other current liabilities Other Liabilities [Member] Long-term debt Long-term Debt [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Asset Derivatives, Fair Value Derivative Asset, Fair Value, Gross Asset Liability Derivatives, Fair Value Derivative Liability, Fair Value, Gross Liability Cash Flow Hedging Relationships Net revenues Sales [Member] Amount of Gain or (Loss) Recognized in AOCE (Net of Tax) on Derivative (Effective Portion) Amount of Gain or (Loss) Reclassified from AOCE into Earnings (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Amount of Gain or (Loss) Excluded from the Assessment of Hedge Effectiveness Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Corporate / Other Corporate Other [Member] Corporate other member. Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Third party Revenues Intersegment Segment Reporting Information, Intersegment Revenue Total Segment Reporting Information, Revenue for Reportable Segment Segment profitability Operating Income (Loss) Supply Commitment [Table] Supply Commitment [Table] Supply Commitment [Axis] Supply Commitment [Axis] Supply Commitment Arrangement [Domain] Supply Commitment Arrangement [Domain] Generic Biologic Compounds Collaboration Generic Biologic Compounds Collaboration [Member] Generic Biologic Compounds Collaboration Supply Commitment [Line Items] Supply Commitment [Line Items] Lease expenses Operating Leases, Rent Expense, Net Contingent consideration Other commitment Other Commitment Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] U.S. Revolving Facility Domestic Line of Credit [Member] Alternative Currency Revolving Facility Foreign Line of Credit [Member] Subfacility for Letters of Credit Subfacility for Letters of Credit [Member] Subfacility for Letters of Credit Subfacility for Swing Line Borrowings Subfacility for Swing Line Borrowings [Member] [Member] Subfacility for Swing Line Borrowings [Member] [Member] Incremental Commitment Subject to Lender Approval Incremental Commitment Subject to Lender Approval [Member] Incremental Commitment Subject to Lender Approval Frequency [Axis] Frequency [Axis] Frequency [Axis] Frequency [Domain] Frequency [Domain] [Domain] for Frequency [Axis] Quarterly Quarterly [Member] Quarterly [Member] Line of Credit Line of Credit [Member] Revolving Facility Revolving Credit Facility [Member] Floating Rate Floating Rate [Member] Floating rate. Swapped To Fixed Rate 2016 Senior Credit Facilities Senior Credit Facilities [Member] Senior Credit Facilities Interest Rate Type [Axis] Interest Rate Type [Axis] Interest Rate Type [Axis] Interest Rate Type [Domain] Interest Rate Type [Domain] [Domain] for Interest Rate Type [Axis] LIBOR Plus Market Rate Spreads LIBOR Plus Market Rate Spreads [Member] LIBOR Plus Market Rate Spreads [Member] Lender's Base Rate Plus Market Rate Spreads Lender's Base Rate Plus Market Rate Spreads [Member] Lender's Base Rate Plus Market Rate Spreads [Member] Revolving facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Line of credit facility, amount outstanding Line of Credit Facility, Amount Outstanding Repayments of debt Repayments of Debt Interest rate during period Line of Credit Facility, Interest Rate During Period Limitation on secured pledge of outanding voting stock of foreign holding companies and subsidiaries Limitation on Secured Pledge of Outstanding Voting Stock Of Foreign Holding Companies And Subsidiaries Limitation on secured pledge of outstanding voting stock of foreign holding companies and subsidiaries Facility fee percentage Line of Credit Facility, Commitment Fee Percentage Quarterly repayments in 2013 Quarterly repayments in 2014 Quarterly repayments in 2015 Quarterly repayments in 2016 Leverage ratio threshold Senior Credit Agreement terms Leverage Ratio Threshold Senior Credit Agreement Terms Leverage Ratio Threshold Senior Credit Agreement Terms Accounting Policies [Table] Major Customers [Axis] Major Customers [Axis] Name of Major Customer [Domain] Name of Major Customer [Domain] Cardinal Health Inc Cardinal Health Inc [Member] Cardinal Health Inc [Member] McKesson Corporation McKesson Corporation [Member] McKesson Corporation [Member] Accounts Receivable Accounts Receivable [Member] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Working Capital Facilities Working Capital Facilities [Member] Working capital facilities that are secured by current assets and property, plant and equipment Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Machinery And Equipment Machinery and Equipment [Member] Buildings And Improvements Building and Building Improvements [Member] Accounting Policies [Line Items] Property, Plant and Equipment [Line Items] Concentration risk, percentage Concentration Risk, Percentage Concentration risk, number of customers Concentration Risk, Additional Characteristic Total allowances for doubtful accounts Allowance for Doubtful Accounts Receivable Property, plant and equipment, estimated service life Property, Plant and Equipment, Useful Life Depreciation expense Depreciation Finite-lived intangible asset, estimated useful life Short-term borrowings, weighted average interest rate Short-term Debt, Weighted Average Interest Rate Sales allowances, current Sales Allowances Current Sales allowances that are recorded in a contra account to accounts receivable. Accrued sales allowances and other adjustments Accrued Sales Allowances Other Current Certain sales allowances and other adjustments that are paid to indirect customers. Accounts receivable from securitization Percentage of consolidated net revenues Entity-Wide Revenue, Major Customer, Percentage Preferred stock, common shares convertible Annual rate of preferred stock dividend Preferred Stock, Dividend Rate, Percentage Aggregate principal amount Aggregate amount of warrants issued Exercise price of warrants issued Stock repurchased during period, shares Stock repurchased during period, value Anti-dilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Income tax provision (benefit), Federal, Current Current Federal Tax Expense (Benefit) Income tax provision (benefit), Federal, Deferred Deferred Federal Income Tax Expense (Benefit) Income tax provision (benefit), Federal Federal Income Tax Expense (Benefit), Continuing Operations Income tax provision (benefit), State and Puerto Rico, Current Current State and Local Tax Expense (Benefit) Income tax provision (benefit), State and Puerto Rico, Deferred Deferred State and Local Income Tax Expense (Benefit) Income tax provision (benefit), State and Puerto Rico State and Local Income Tax Expense (Benefit), Continuing Operations Income tax provision (benefit), Foreign, Current Current Foreign Tax Expense (Benefit) Income tax provision (benefit), Foreign, Deferred Deferred Foreign Income Tax Expense (Benefit) Income tax provision (benefit), Foreign Foreign Income Tax Expense (Benefit), Continuing Operations Income tax provision Income Tax Expense (Benefit), Continuing Operations Earnings (loss) before income taxes and noncontrolling interest: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract] Earnings before income taxes and noncontrolling interest, Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Earnings before income taxes and noncontrolling interest, Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Earnings before income taxes and noncontrolling interest Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Summary Of Significant Accounting Policies Significant Accounting Policies [Text Block] Derivative [Table] Derivative [Table] Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis] Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis] Fair Value, Disclosure Item Amounts [Domain] Fair Value, Disclosure Item Amounts [Domain] Change During Period, Fair Value Disclosure Change During Period, Fair Value Disclosure [Member] Payment Payment [Member] Payment Floating rate debt Fixed rate debt Fixed Rate Debt [Member] Fixed Rate Debt [Member] Derivative instrument contracts with credit-risk-related contingent features Credit Risk Related Contingent Features [Member] Credit Risk Related Contingent Features [Member] Notional amount of derivative instruments designated as net investment hedges Notional Amount of Derivative Instruments Designated as Net Investment Hedges Notional amount of interest rate fair value hedge derivatives Notional Amount of Interest Rate Fair Value Hedge Derivatives Interest rate cash flow hedge gain (loss) reclassified to earnings, net Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net Aggregate fair value of derivative contracts Derivative Assets (Liabilities), at Fair Value, Net Fair value of convertible note hedge Credit Risk Derivatives, at Fair Value, Net Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Amount of gain recognized in earnings on derivatives Accretion expense Accretion Expense Adjustment to contingent consideration liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Property, Plant and Equipment [Table] Schedule of Property, Plant and Equipment [Table] Land and improvements Land and Land Improvements [Member] Buildings and improvements Machinery and equipment Construction in progress Construction in Progress [Member] Property, Plant and Equipment [Line Items] Property, plant and equipment, gross Property, Plant and Equipment, Gross Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total property, plant and equipment, net Schedule of Comprehensive Earnings (Loss) Schedule of Comprehensive Income (Loss) [Table Text Block] Schedule of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Other Other Long Term Debt [Member] Other long term debt. Long-term debt Long-term debt, excluding current maturities Statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate State income taxes and credits Effective Income Tax Rate Reconciliation, Tax Credits Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential Other foreign items Effective Income Tax Rate Reconciliation, Tax Settlements, Foreign Uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Contingencies Net benefit on repatriated earnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance Other Effective Income Tax Rate Reconciliation, Other Adjustments Effective tax rate Effective Income Tax Rate, Continuing Operations Valuation and Qualifying Accounts [Abstract] Valuation and Qualifying Accounts Disclosure [Table] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves [Domain] Valuation Allowances and Reserves [Domain] Allowance for doubtful accounts Allowance for Doubtful Accounts [Member] Valuation allowance for deferred tax assets Valuation Allowance of Deferred Tax Assets [Member] Valuation and Qualifying Accounts Disclosure [Line Items] Valuation and Qualifying Accounts Disclosure [Line Items] Movement in Valuation Allowances and Reserves [Roll Forward] Movement in Valuation Allowances and Reserves [Roll Forward] Beginning Balance Valuation Allowances and Reserves, Balance Additions Charged to Costs and Expenses Valuation Allowances and Reserves, Charged to Cost and Expense Additions Charged to Other Accounts Valuation Allowances and Reserves, Charged to Other Accounts Deductions Valuation Allowances and Reserves, Deductions Ending Balance Schedule of Other Current Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule of Accrued Liabilities Schedule Of Other Current Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] [Line Items] for Schedule of Accrued Liabilities Legal and professional accruals, including litigation accruals Estimated Litigation Liability, Current Payroll and employee benefit plan accruals Employee-related Liabilities, Current Accrued sales allowances Accrued interest Interest Payable, Current Fair value of financial instruments Derivative Instruments and Hedges, Liabilities Other Other Sundry Liabilities, Current Total other current liabilities Schedule II - Valuation and Qualifying Accounts Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Nature of Operations Nature of Operations [Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Convertible Preferred Stock Convertible Preferred Stock Subject to Mandatory Redemption [Member] Class of Stock [Line Items] Class of Stock [Line Items] Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Convertible preferred stock, shares issued Preferred Stock, Shares Issued Convertible preferred stock dividend rate, percentage Value of issued common stock, per share Stock Issued, Price Per Share, New Issues Stock Issued, Price Per Share, New Issues Issuance of common stock Common Stock, Shares, Issued Preferred stock, liquidation preference per share Preferred Stock, Liquidation Preference Per Share Convertible preferred stock, shares issued upon conversion Convertible Preferred Stock, Shares Issued upon Conversion Preferred dividends Dividends, Preferred Stock Segment Information Segment Reporting Disclosure [Text Block] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] United States UNITED STATES Other Americas Segment, Geographical, Groups of Countries, Group One [Member] Europe Segment, Geographical, Groups of Countries, Group Two [Member] France FRANCE Asia Segment Geographical Groups Of Countries Group Three [Member] Segment Geographical Groups Of Countries Group Three [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Treasury stock, shares Treasury Stock, Shares Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class Allergy Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] [Line Items] for Schedule of Product Rights and Licenses by Therapeutic Class Finite-lived intangible assets, net Income Statement [Abstract] Revenues: Revenue, Net [Abstract] Net revenues Other revenues Other Revenue, Net Total revenues Cost of sales Cost of Goods and Services Sold Gross profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Litigation settlements, net Total operating expenses Operating Expenses Earnings from operations Interest expense Interest Expense Other income (expense), net Other Nonoperating Income (Expense) Income tax provision Income Tax Expense (Benefit) Net earnings Net earnings attributable to the noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Net earnings attributable to Mylan Inc. before preferred dividends Net earnings attributable to Mylan Inc. common shareholders Basic Diluted Income Tax Contingency [Table] Income Tax Contingency [Table] Limitation of Use [Axis] Limitation of Use [Axis] Limitation of Use [Axis] Limitation of Use [Domain] Limitation of Use [Domain] [Domain] for Limitation of Use [Axis] Percentage Percentage [Member] Percentage Monetary Monetary [Member] Monetary Carried Forward Indefinitely Indefinite [Member] Indefinite amount of time Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] State and Local Jurisdiction State and Local Jurisdiction [Member] Foreign Country Foreign Tax Authority [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Amount of unrecognized deferred tax liability Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability Valuation allowance, amount Valuation Allowance, Amount Valuation allowance, deferred tax asset, change in amount Valuation Allowance, Deferred Tax Asset, Change in Amount Net operating loss carryforwards Operating Loss Carryforwards Net operating loss carryforward, limitation on use Other Tax Carryforward, Limitations on Use Tax credit carryforward, amount Tax Credit Carryforward, Amount Tax credit carryforward, valuation allowance Tax Credit Carryforward, Valuation Allowance Capital loss carryforward Capital Loss Carryforward Capital loss carryforward. Unrecognized tax benefit Unrecognized tax benefits that would impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Accrued interest and penalties Income Tax Examination, Penalties and Interest Accrued Interest (income) expense related to uncertain tax positions Income Tax Examination, Interest Expense Estimated change in unrecognized tax benefits possible within next 12 months, lower bound Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound Estimated change in unrecognized tax benefits possible within next 12 months, upper bound Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound Accumulated other comprehensive income (loss), available-for-sale securities adjustment, net of tax Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Net unrecognized losses and prior service costs related to defined benefit plans, net of tax Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, effect net of tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Accumulated other comprehensive income (loss), foreign currency translation adjustment, net of tax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Accumulated other comprehensive income (loss), net of tax Summary Of Long-Term Debt Schedule of Debt [Table Text Block] Interest Rates On Outstanding Borrowings Under Term Loans Schedule of Long-term Debt Instruments [Table Text Block] Minimum Repayments On Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Inventories Schedule of Inventory, Current [Table Text Block] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of Shares Under Option - Outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Weighted Average Exercise Price per Share - Outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Number of Shares Under Option - Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Weighted Average Exercise Price per Share - Options granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Number of Shares Under Option - Options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Weighted Average Exercise Price per Share - Options exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Number of Shares Under Option - Options forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Weighted Average Exercise Price per Share - Options forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of Shares Under Option - Outstanding at end of period Weighted Average Exercise Price per Share - Outstanding at end of period Number of Shares Under Option - Vested and expected to vest at December 31, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Weighted Average Exercise Price per Share - Vested and expected to vest at December 31, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Number of Shares Under Option - Options exercisable at December 31, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted Average Exercise Price per Share - Options exercisable at December 31, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Postretirement Benefits, Type of Deferred Compensation [Axis] Postretirement Benefits, Type of Deferred Compensation [Axis] Type of Deferred Compensation, All Types [Domain] Type of Deferred Compensation, All Types [Domain] Base Salary Deferred Base Salary [Member] Deferred Base Salary [Member] Deferred Bonus Deferred Bonus [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Workforce Subject to Collective Bargaining Arrangements Workforce Subject to Collective Bargaining Arrangements [Member] Multiemployer Plan, Plan Information [Axis] Multiemployer Plan, Plan Information [Axis] Multiemployer Plan, Plan Information [Domain] Multiemployer Plan, Plan Information [Domain] Efffective for Fund in Critical Status [Member] Efffective for Fund in Critical Status [Member] Effective Each Plan Year in which the Fund is in Critical Status Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Accrued benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Defined contribution plan, maximum annual contribution per employee, percent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent Total employer contributions Defined Contribution Plan, Cost Recognized Multiemployer plans, withdrawal obligation Multiemployer Plans, Withdrawal Obligation Percentage of entity employees Entity Number of Employees Contribution recognized as expenses Multiemployer Plan, Period Contributions Employer's contribution percentage in excess of total contribution Multiemployer Plans, Period Contributions, Significance of Contributions Pension plan funded percentage critical status threshold Multiemployer Plans, Funded Status Multiemployer Plans, Contribution Rate Increase (Decrease) Multiemployer Plans, Contribution Rate Increase (Decrease) Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] Senior And Senior Convertible Notes Senior And Senior Convertible Notes [Member] Senior and senior convertible notes. Fair value of long-term debt Debt Instrument, Fair Value Disclosure